BL

Bloomios IncOOTC BLMS Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

BLMS Stock Analysis

BL

Uncovered

Bloomios Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-64/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

14.251 B

Website

Bloomios, Inc. is engaged in the manufacturing, marketing, and distribution of U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels and its subsidiary. The company is headquartered in Santa Barbara, California. The company went IPO on 2003-10-14. The firm manufactures hemp-infused products ranging from human edibles, pet edibles, liquid consumables, such as tinctures and shots, topicals, and smokable hemp. The company provides custom formulation, brand development, manufacturing and order fulfillment to a range of customers, including small and brands, chain stores, vape shops and distributors. The firm's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. The company offers its private-label and white-label customers collections of customizable hemp products that include over 80 products across seven categories in addition to custom formulation and manufacturing services. The company has operations in Daytona Beach, Florida. The company also has cannabidiol (CBD) assets.

View Section: Eyestock Rating